Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2011-10-05 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
111005 - shares acquisition_NL.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Openbaarmaking inkoop eigen aandelen" (Disclosure share repurchase) and explicitly states that UCB SA/NV bought back 1,114,259 of its own shares on September 29, 2011. This action directly relates to the company acquiring its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS), which covers share repurchases.
2011-10-05 Dutch
UCB's Board of Directors elected New Chairman for 2012
Board/Management Information Classification · 99% confidence The document is titled with a specific announcement: "UCB's Board of Directors elected New Chairman for 2012". The content details the election of Gerhard Mayr as the new Chairman, replacing Karel Boone, and provides extensive biographical information on both individuals, who are members of the Board of Directors. This directly relates to changes in the company's senior management and board structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS).
2011-09-23 English
Le conseil d’administration d’UCB a élu un nouveau président pour 2012
Board/Management Information Classification · 99% confidence The document is a press release, indicated by the structure, the date (September 23, 2011), the mention of 'information réglementée' (regulated information), and the contact details for Investor Relations and Communications. The core content announces a change in the Chairman of the Board of Directors (Gerhard Mayr succeeding Karel Boone) effective April 2012. This specific event—the announcement of changes in the company's board of directors or senior management—directly matches the definition for Board/Management Information (MANG). It is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2011-09-23 French
De raad van bestuur van UCB koos een nieuwe voorzitter voor 2012
Board/Management Information Classification · 99% confidence The document is a press release dated September 23, 2011, originating from Brussels, Belgium, and explicitly labeled as 'gereglementeerde informatie' (regulated information). The core content announces a change in leadership: the Board of Directors elected Gerhard Mayr as the new Chairman, succeeding Karel Boone. This directly relates to changes in the company's senior management and board structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not an earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific management transition.
2011-09-23 Dutch
110922 Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document explicitly details the acquisition of UCB shares by the company itself, stating, "Acquisition of own shares in the framework of employees' long-term incentive plans" and providing a table showing the date, price, and amount of shares acquired. This directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document is short and structured like a regulatory disclosure/press release regarding this specific transaction.
2011-09-22 English
110922 Acquisition of own shares_FR.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Acquisition d'actions propres dans le cadre de rémunérations variables à long terme du personnel" (Acquisition of own shares under long-term variable remuneration for personnel). It explicitly states that UCB acquired 2,500 of its own shares on the stock exchange and delivered them to employees who exercised stock options. This action directly corresponds to the definition of a company buying back or selling its own shares for internal purposes, which maps precisely to the 'Transaction in Own Shares' category (POS). The document is a regulatory announcement detailing this specific transaction.
2011-09-22 French

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.